日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease

2型糖尿病和代谢功能障碍相关脂肪肝的流行病学、筛查和联合管理

Qi, Xiaolong; Li, Jie; Caussy, Cyrielle; Teng, Gao-Jun; Loomba, Rohit

Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply

将高危代谢功能障碍相关脂肪性肝炎的诊断率提高一倍——不让任何人掉队:作者回复

Lazarus, Jeffrey V; Alazawi, William; Byrne, Christopher D; Caussy, Cyrielle; Brennan, Paul N

Management of obesity in advanced chronic liver disease

晚期慢性肝病肥胖症的管理

Caussy, Cyrielle; Francque, Sven M

Weight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines

体重变化与一般人群的代谢性肝脏健康相关,这种关联超越了国际指南规定的减重目标。

van Kleef, Laurens A; Savas, Mesut; Michel, Maurice; Caussy, Cyrielle; Pustjens, Jesse; Holleboom, Adriaan G; van Rossum, Elisabeth F C; Janssen, Harry L A; Schattenberg, Jörn M; Brouwer, Willem P

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis

呼吁将高危代谢功能障碍相关脂肪性肝炎的诊断率提高一倍

Lazarus, Jeffrey V; Brennan, Paul N; Mark, Henry E; Alazawi, William; Allen, Alina M; Byrne, Christopher D; Castera, Laurent; Caussy, Cyrielle; Cusi, Kenneth; Grajower, Martin M; Kopka, Christopher J; Massoels, Jo; Roden, Michael; Spearman, C Wendy; Tacke, Frank; Wong, Vincent Wai-Sun; Noureddin, Mazen

Multifunctional dietary approach reduces intestinal inflammation in relation with changes in gut microbiota composition in subjects at cardiometabolic risk: the SINFONI project

多功能饮食方案通过改变肠道菌群组成来降低心血管代谢风险人群的肠道炎症:SINFONI 项目

Hornero-Ramirez, Hugo; Morisette, Arianne; Marcotte, Bruno; Penhoat, Armelle; Lecomte, Béryle; Panthu, Baptiste; Lessard Lord, Jacob; Thirion, Florence; Van-Den-Berghe, Laurie; Blond, Emilie; Simon, Chantal; Caussy, Cyrielle; Feugier, Nathalie; Doré, Joël; Sanoner, Philippe; Meynier, Alexandra; Desjardins, Yves; Pilon, Geneviève; Marette, André; Cani, Patrice D; Laville, Martine; Vinoy, Sophie; Michalski, Marie-Caroline; Nazare, Julie-Anne

The Gut Microbiome and the Gut-Liver-Kidney Axis in Metabolic Dysfunction-Associated Steatotic Liver Disease

肠道微生物群与代谢功能障碍相关脂肪肝疾病中的肠-肝-肾轴

Caussy, Cyrielle; Rieusset, Jennifer; Koppe, Laetitia

A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

一项旨在识别代谢功能障碍相关脂肪肝疾病管理挑战的欧洲调查

Castera, Laurent; Alazawi, William; Bugianesi, Elisabetta; Caussy, Cyrielle; Federici, Massimo; Romero-Gómez, Manuel; Schattenberg, Jörn M; Basuroy, Ron; Prasad, Preethy; Estulin, Dmitry; Lazarus, Jeffrey V

Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus

代谢功能障碍相关脂肪肝与2型糖尿病之间存在密切的多层次联系

Holleboom, A G; Francque, S M; Cusi, K; Caussy, C

N-acetyl-phenylalanine induces hepatic steatosis in MASLD by disrupting ER-mitochondria calcium coupling and mitochondrial lipid oxidation

N-乙酰苯丙氨酸通过破坏内质网-线粒体钙偶联和线粒体脂质氧化,诱导MASLD患者发生肝脂肪变性。

Lefebvre, Rémy; Rousseaux, Théo; Bendridi, Nadia; Chanon, Stéphanie; Arquier, Delphine; Humbert, Alexandre; Bertocchini, Nicolas; Pillot, Bruno; Meugnier, Emmanuelle; Vieille-Marchiset, Aurélie; Nawrot, Margaux; Pinteur, Claudie; Ayciriex, Sophie; Loomba, Rohit; Rieusset, Jennifer; Caussy, Cyrielle